WallStreetZenWallStreetZen

NASDAQ: ACST
Acasti Pharma Inc Stock Forecast, Predictions & Price Target

Analyst price target for ACST

Based on 1 analyst offering 12 month price targets for Acasti Pharma Inc.
Min Forecast
$6.00+85.99%
Avg Forecast
$6.00+85.99%
Max Forecast
$6.00+85.99%

Should I buy or sell ACST stock?

Based on 1 analyst offering ratings for Acasti Pharma Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ACST stock forecasts and price targets.

ACST stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-07

1 of 1

Forecast return on equity

Is ACST forecast to generate an efficient return?
Company
-5.23%
Industry
76.4%
Market
82.5%
ACST's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ACST forecast to generate an efficient return on assets?
Company
-4.44%
Industry
31.02%
ACST is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ACST earnings per share forecast

What is ACST's earnings per share in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$1.29
Avg 2 year Forecast
-$0.93
Avg 3 year Forecast
-$0.36

ACST vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ACST$3.23$6.00+85.99%Buy
PMN$1.61N/AN/A
QNCX$0.71N/AN/A
LSTA$3.60$15.00+316.67%Buy
PTN$1.82$17.00+833.04%Buy

Acasti Pharma Stock Forecast FAQ

Is Acasti Pharma Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ACST) stock is to Buy ACST stock.

Out of 1 analyst, 0 (0%) are recommending ACST as a Strong Buy, 1 (100%) are recommending ACST as a Buy, 0 (0%) are recommending ACST as a Hold, 0 (0%) are recommending ACST as a Sell, and 0 (0%) are recommending ACST as a Strong Sell.

If you're new to stock investing, here's how to buy Acasti Pharma stock.

What is ACST's earnings growth forecast for 2025-2027?

(NASDAQ: ACST) Acasti Pharma's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.88%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.82%.

Acasti Pharma's earnings in 2024 is -$38,774,000.On average, 1 Wall Street analyst forecast ACST's earnings for 2025 to be -$12,125,231, with the lowest ACST earnings forecast at -$12,125,231, and the highest ACST earnings forecast at -$12,125,231. On average, 1 Wall Street analyst forecast ACST's earnings for 2026 to be -$8,741,446, with the lowest ACST earnings forecast at -$8,741,446, and the highest ACST earnings forecast at -$8,741,446.

In 2027, ACST is forecast to generate -$3,383,785 in earnings, with the lowest earnings forecast at -$3,383,785 and the highest earnings forecast at -$3,383,785.

What is ACST's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: ACST) forecast ROE is -5.23%, which is considered weak.

What is ACST's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ACST price target, the average ACST price target is $6.00, with the highest ACST stock price forecast at $6.00 and the lowest ACST stock price forecast at $6.00.

The Wall Street analyst predicted that Acasti Pharma's share price could reach $6.00 by Feb 7, 2025. The average Acasti Pharma stock price prediction forecasts a potential upside of 85.99% from the current ACST share price of $3.23.

What is ACST's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ACST) Acasti Pharma's current Earnings Per Share (EPS) is -$5.08. On average, analysts forecast that ACST's EPS will be -$1.29 for 2025, with the lowest EPS forecast at -$1.29, and the highest EPS forecast at -$1.29. On average, analysts forecast that ACST's EPS will be -$0.93 for 2026, with the lowest EPS forecast at -$0.93, and the highest EPS forecast at -$0.93. In 2027, ACST's EPS is forecast to hit -$0.36 (min: -$0.36, max: -$0.36).

What is ACST's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: ACST) forecast ROA is -4.44%, which is lower than the forecast US Biotechnology industry average of 31.02%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.